Itama Ranoraya
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more
Itama Ranoraya - Asset Resilience Ratio
Itama Ranoraya (IRRA) has an Asset Resilience Ratio of 1.56% as of September 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how Itama Ranoraya's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Itama Ranoraya's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp12.09 Billion | 1.56% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp12.09 Billion | 1.56% |
Asset Resilience Insights
- Limited Liquidity: Itama Ranoraya maintains only 1.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Itama Ranoraya Industry Peers by Asset Resilience Ratio
Compare Itama Ranoraya's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for Itama Ranoraya (2016–2023)
The table below shows the annual Asset Resilience Ratio data for Itama Ranoraya.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | Rp0.00 | Rp1.06 Trillion | -- |
| 2021-12-31 | 0.00% | Rp0.00 | Rp782.04 Billion | -- |
| 2020-12-31 | 21.48% | Rp115.00 Billion | Rp535.27 Billion | -9.24pp |
| 2019-12-31 | 30.73% | Rp100.00 Billion | Rp325.43 Billion | +21.19pp |
| 2018-12-31 | 9.54% | Rp13.00 Billion | Rp136.26 Billion | -16.31pp |
| 2017-12-31 | 25.85% | Rp33.00 Billion | Rp127.67 Billion | -- |
| 2016-12-31 | 0.00% | Rp0.00 | Rp27.20 Billion | -- |